Amirkalali B, Sharifi F, Fakhrzadeh H, Mirarefein M, Ghaderpanahi M, Badamchizadeh Z, et al. Low serum leptin serves as a biomarker of malnutrition in elderly patients. Nutrition Research. 2010;30(5):314–9.
2.
Stattin P, Söderberg S, Olsson T, Hallmans G, Lenner P, Biessy C, et al. Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden. Breast Cancer Research and Treatment. 2004;86(3):191–6.
3.
Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D. Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes & Control. 2000;11(5):383–8.
4.
Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, et al. Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line. Journal of Biological Chemistry. 2003;278(31):28668–76.
5.
Han C, Zhang HT, Du L, Liu X, Jing J, Zhao X, et al. Serum Levels of Leptin, Insulin, and Lipids in Relation to Breast Cancer in China. Endocrine. 26(1):019–24.
6.
Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, et al. Leptin expression in colorectal and breast cancer patients. International Journal of Molecular Medicine.
7.
Al-Zeidaneen SA, Ahmad MN, Al-Ebuos AD. The impact of treatment exposure on diabetes biomarkers among Jordanian breast cancer women: a connection through FBG, C-peptide and HOMA-IR. Current Gynecologic Oncology. 2017;15(4):231–8.
8.
Al-Zeidaneen S, Ahmad M, Al-Ebouse A. Interactive role of obesity indices on breast cancer severity in Jordanian women. EJBPS. 2017;4:637–44.
9.
Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, et al. Evidence That Glucose Metabolism Regulates Leptin Secretion from Cultured Rat Adipocytes*. Endocrinology. 1998;139(2):551–8.
10.
Kahn BB, Flier JS. Obesity and insulin resistance. Journal of Clinical Investigation. 2000;106(4):473–81.
11.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans. New England Journal of Medicine. 1996;334(5):292–5.
12.
Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, et al. Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer? Journal of Clinical Oncology. 2005;23(25):6037–42.
13.
Al-Zeidaneen S, Ahmad M, Al-Ebouse A. The risk of malnutrition among breast cancer women as related to their dietary intakes in Jordan. In: 2015 Conference: The 7th Conference on Scientific Research in Jordan Organized by The Jordan Society for Scientific Research.
14.
Bouillanne O, Golmard JL, Coussieu C, Noël M, Durand D, Piette F, et al. Leptin a new biological marker for evaluating malnutrition in elderly patients. European Journal of Clinical Nutrition. 2007;61(5):647–54.
15.
Cederholm T, Arner P, Palmblad J. Low circulating leptin levels in protein‐energy malnourished chronically ill elderly patients. Journal of Internal Medicine. 1997;242(5):377–82.
16.
Murakami T, Yamashita T, Iida M, Kuwajima M, Shima K. A Short Form of Leptin Receptor Performs Signal Transduction. Biochemical and Biophysical Research Communications. 1997;231(1):26–9.
17.
Surmacz E. Obesity hormone leptin: a new target in breast cancer? Breast Cancer Research. 2007;9(1).
18.
Yun JE, Kimm H, Jo J, Jee SH. Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations. Metabolism. 2010;59(3):424–9.
19.
Lyoussi B, Ragala MA, M’guil M, Chraibi A, Israili ZH. Gender-Specific Leptinemia and Its Relationship with Some Components of the Metabolic Syndrome in Moroccans. Clinical and Experimental Hypertension. 2005;27(4):377–94.
20.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
21.
Obesity: Preventing and Managing the Global Epidemic. 2000.
22.
Lee RD, Assessement NDCN. 2010.
23.
Arkoob K, Al Nsour M, Al Nemry O, Al Hajawi B. Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis. Eastern Mediterranean Health Journal. 2010;16(10):1032–8.
24.
Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Experimental & Molecular Medicine. 33(2):95–102.
25.
Carroll PA, Healy L, Lysaght J, Boyle T, Reynolds JV, Kennedy MJ, et al. Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer. Molecular Carcinogenesis. 2011;50(8):643–51.
26.
Anubhuti, Arora S. Leptin and its metabolic interactions – an update. Diabetes, Obesity and Metabolism. 2008;10(11):973–93.
27.
Garofalo C, Surmacz E. Leptin and cancer. Journal of Cellular Physiology. 2006;207(1):12–22.
28.
Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, et al. Circulating levels of leptin, adiposity and breast cancer risk. British Journal of Cancer. 2009;100(4):578–82.
29.
Artac M, Altundag K. Leptin and breast cancer: an overview. Medical Oncology. 2012;29(3):1510–4.
30.
Zamboni M, Zoico E, Fantin F, Panourgia MP, Di Francesco V, Tosoni P, et al. Relation Between Leptin and the Metabolic Syndrome in Elderly Women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2004;59(4):M396–400.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
